Boniva 150 Mg, FC Tablets 150 mg FC tablets
PDF Leaflet Revision Date: 17 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of osteoporosis in postmenopausal women to reduce vertebral fracture risk.
Dosage (summary)
150 mg once monthly after an overnight fast.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation; potential reproductive toxicity.
Key Drug Interactions
- Calcium supplements
- Antacids
- NSAIDs
Contraindications
- Hypersensitivity to ibandronic acid
- Hypocalcaemia
- Severe renal impairment
- Oesophageal abnormalities
- Inability to sit upright
Common side effects
- Arthralgia
- Influenza-like symptoms
- Headache
- Gastrointestinal irritation
Counselling Points
- Take after an overnight fast
- Do not lie down for 1 hour after taking
- Report any thigh or groin pain
Serious warnings
- Osteonecrosis of the jaw
- Atypical femoral fractures
- Gastrointestinal irritation
Important Disclaimer
The Boniva 150 Mg, FC Tablets 150 mg FC tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
